期刊文献+

Gastric-and intestinal-type marker expression in invasive ductal adenocarcinoma of the pancreas 被引量:1

Gastric-and intestinal-type marker expression in invasive ductal adenocarcinoma of the pancreas
下载PDF
导出
摘要 BACKGROUND:Although invasive ductal adenocarcinoma of the pancreas(PDAC) manifests as a relatively uniform histomorphological feature of the pancreatobiliary type,it may be complicated by metaplastic changes and heterogeneous gastric and intestinal elements.This study aimed to investigate the complication rate and clinicopathological significance of such heterogeneous elements.METHODS:Fifty-nine patients who underwent resection of PDAC were examined in this study.Immunohistochemically,tumors showing high expression(>25%) of the intestinal-type(INT) marker CDX2 were classified as PDAC with INT.Those with high expression(>25%) of the gastric-type(GAS) marker MUC5AC were classified as PDAC with GAS,while those with high expression of both markers were classified as PDAC with INT/GAS.These patients were compared with those with PDAC of the negative group in which neither markers was highly expressed to examine their clinicopathological significance.RESULTS:In the 59 patients,31(52.5%) showed high CDX2 or MUC5AC expression.Twenty-eight patients(47.5%) belonged to a negative group,11(18.6%) to a PDAC with INT group,15(25.4%) to a PDAC with GAS group,and 5(8.5%) to a PDAC with INT/GAS group.No significant differences were observed for age,gender,size,localization,T classification,or prognosis among the four groups.Although the PDAC with GAS group had well differentiated types significantly more than the other groups,the rate of lymph node metastasis in this group was significantly higher(PDAC with GAS:73%;other groups:36%).CONCLUSION:Complications with heterogeneous elements are not uncommon in PDAC,and this should be considered during the diagnosis and treatment of PDAC along with histogenesis of the disease. BACKGROUND:Although invasive ductal adenocarcinoma of the pancreas(PDAC) manifests as a relatively uniform histomorphological feature of the pancreatobiliary type,it may be complicated by metaplastic changes and heterogeneous gastric and intestinal elements.This study aimed to investigate the complication rate and clinicopathological significance of such heterogeneous elements.METHODS:Fifty-nine patients who underwent resection of PDAC were examined in this study.Immunohistochemically,tumors showing high expression(>25%) of the intestinal-type(INT) marker CDX2 were classified as PDAC with INT.Those with high expression(>25%) of the gastric-type(GAS) marker MUC5AC were classified as PDAC with GAS,while those with high expression of both markers were classified as PDAC with INT/GAS.These patients were compared with those with PDAC of the negative group in which neither markers was highly expressed to examine their clinicopathological significance.RESULTS:In the 59 patients,31(52.5%) showed high CDX2 or MUC5AC expression.Twenty-eight patients(47.5%) belonged to a negative group,11(18.6%) to a PDAC with INT group,15(25.4%) to a PDAC with GAS group,and 5(8.5%) to a PDAC with INT/GAS group.No significant differences were observed for age,gender,size,localization,T classification,or prognosis among the four groups.Although the PDAC with GAS group had well differentiated types significantly more than the other groups,the rate of lymph node metastasis in this group was significantly higher(PDAC with GAS:73%;other groups:36%).CONCLUSION:Complications with heterogeneous elements are not uncommon in PDAC,and this should be considered during the diagnosis and treatment of PDAC along with histogenesis of the disease.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2012年第4期424-428,共5页 国际肝胆胰疾病杂志(英文版)
关键词 ductal adenocarcinoma pancreatic neoplasms gastric-type intestinal-type IMMUNOHISTOCHEMISTRY ductal adenocarcinoma pancreatic neoplasms gastric-type intestinal-type immunohistochemistry
  • 相关文献

参考文献13

  • 1Suguru Yonezawa,Michiyo Higashi,Norishige Yamada,Seiya Yokoyama,Masamichi Goto.Significance of mucin expression in pancreatobiliary neoplasms[J]. Journal of Hepato - Biliary - Pancreatic Sciences . 2010 (2)
  • 2Neoptolemos J P,Dunn J A,Stocken D D,et al.Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet,The . 2001
  • 3Oettle H,Post S,Neuhaus P,Gellert K,Langrehr J,Ridwelski K, et al.Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. The Journal of The American Medical Association . 2007
  • 4B Sipos,S Frank,T Gress,S Hahn,G Kloppel.Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology . 2009
  • 5Yamazoe S,Tanaka H,Sawada T,Amano R,Yamada N.RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells. Journal of Experimental and Clinical Cancer Research . 2010
  • 6Hoshi H,Sawada T,,Uchida M,et al.Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer. International Journal of Oncology . 2011
  • 7CR Ferrone,MW Kattan,JS Tomlinson,SP Thayer,MF Brennan,AL Warshaw.Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. Journal of Clinical Oncology . 2005
  • 8Park SY,Roh SJ,Kim YN,Kim SZ,Park HS,Jang KY,Chung MJ,Kang MJ,Lee DG,Moon WS.Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncology Reports . 2009
  • 9Zalatnai A,Molnár J.Molecular background of chemoresistance in pancreatic cancer. In Vivo . 2007
  • 10Aloysius MM,Zaitoun AM,Awad S,Ilyas M,Rowlands BJ,Lobo DN.Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer. British Journal of Surgery . 2010

共引文献1

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部